Schmid John P. (CIK 1478916) reported 8 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy ANAB (6,030 shares), Buy TRAX (6,030 shares), Sell ANAB (11,068 shares), Buy BBOT (30,000 shares), Buy ANAB (6,030 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 6,030 | $0 |
| 2026-06-17 | First Tracks Biotherapeutics, Inc. (TRAX) | Director | Buy | 6,030 | $0 |
| 2025-12-23 | ANAPTYSBIO, INC (ANAB) | Director | Sell | 11,068 | $564,468 |
| 2025-08-11 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Insider | Buy | 30,000 | $0 |
| 2025-06-17 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 6,030 | $0 |
| 2025-03-27 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 11,068 | $201,216 |
| 2025-01-15 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 21,692 | $98,699 |
| 2025-01-15 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 20,645 | $176,308 |
Source: SEC Form 4 filings · as of 2026-06-17